Abbott Laboratories is keeping up the legal barrage against an Israeli generic drugmaker, this time accusing Teva Pharmaceutical Industries of infringing on the patent used to treat men with low testosterone levels.
Abbott slaps Israeli firm with patent suit
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.